Accelerator™ Drug Development: Driving Global Clinical Research Success Through Integrated Governance

Coordinating large-scale clinical research programs across multiple geographies, vendors, and timelines often creates complexity and risk. Fragmented systems, limited visibility, and misaligned priorities can quickly slow progress impacting enrollment, execution, and delivery.

A global biopharma organization faced these challenges while managing a clinical program spanning 450+ sites and 800 patients at different stages of development. Using Thermo Fisher Scientific’s Accelerator™ Drug Development, they achieved stronger oversight and streamlined performance through a single-vendor model that unified operations and governance across regions.

Download the case study to discover how integrated governance enabled smoother execution and faster, more reliable outcomes.